FDA Inspection 1238483 — Se-Hoon Lee, MD
The FDA completed an inspection of Se-Hoon Lee, MD on Apr 19, 2024 in Gangnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 19, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gangnam (Korea (the Republic of))
Additional Details
Clinical Investigator (CI)